Alphabet Inc. Fulcrum Therapeutics, Inc. Transaction History
Alphabet Inc.
- $2.25 Billion
- Q1 2024
A detailed history of Alphabet Inc. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 14,262 shares of FULC stock, worth $111,956. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,262
Previous 14,262
-0.0%
Holding current value
$111,956
Previous $96,000
39.58%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding FULC
# of Institutions
136Shares Held
43.7MCall Options Held
3.12MPut Options Held
128K-
Rtw Investments, LP New York, NY5.85MShares$45.9 Million0.89% of portfolio
-
Cowen And Company, LLC3.71MShares$29.2 Million1.18% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.85MShares$22.4 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$19.9 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$18.4 Million10.72% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $409M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...